See rule 5. This appendix shall not be changed by sailing instructions or prescriptions of national authorities. When governmental requirements conflict with parts of it, those requirements apply.
Doping is the taking or using by a competitor of a substance or a method banned by the ISAF. Doping is governed by rule 5, this appendix, and the ISAF Medical Lists (containing the official lists of doping classes and methods, medicines that may be taken, and laboratories accredited for doping control) and Doping Control Procedures (the medical procedures leaflet). These publications, doping control forms and the ISAF schedule of penalties are available from ISAF to national authorities and competitors on request.
L1.1 No testing shall be initiated by the organizing authority of an event without the written authority of the ISAF or the national authority having jurisdiction over the event, except that at an event for an Olympic class it may be initiated by the national authority of the competitor to be tested.
L1.2 A competitor selected for testing shall not refuse to be tested and shall appear at a control centre when required by a sampling officer.
L2 Initiation of Doping Control
The ISAF or a national authority may at any time initiate medical testing to control doping within its own jurisdiction or for competitors under its jurisdiction. A sampling officer shall be appointed to administer or supervise the testing.
L3.1 At an authorized event where doping control is undertaken, the protest committee chairman shall select the competitors to be tested on a specific day. Selection may be by means of a draw and specific competitors may be selected, as decided by the protest committee chairman. If on that day a race is postponed to a following day or abandoned, or if a competitor does not start in a race that is taking place, the protest committee chairman may still require the testing of the specific competitor(s) already selected and may select any other competitors to be tested on that day. When there is more than one competitor in each boat, any or all of them may be selected. The race committee shall give to the sampling officer the names of the competitors selected for testing. A competitor may be tested more than once during an event.
L3.2 Testing (doping control) may be undertaken at any time either in competition (during an event) or out-of-competition (between events). No prior consent by the competitor is required.
L4.1 (a) The sampling officer or his representative shall inform a competitor by written notice, in confidence, that he or she has been selected for testing and is required to provide a urine sample at the time and place specified in the notice. The notice shall also specify the name of the sampling officer appointed for the event and of the designated laboratory to which specimens will be sent.
(b) The competitor shall acknowledge receipt of the notice, and the time of its delivery shall be recorded by the sampling officer or his representative.
(c) The competitor may be accompanied by one person of his or her choice.
(d) The Medical Lists and Doping Control Procedures shall be available to the competitor on request.
(e) A competitor who fails to appear at the appointed time and place or who refuses to provide a sample shall be removed, together with the boat in which he or she was sailing, from the event and all its results. The protest committee shall call a hearing in accordance with the rules of Part 5, Section B, to investigate the circumstances and report its findings to the ISAF or to the initiating national authority, and to the national authority of the competitor.
L4.2 The sampling officer and other persons involved in doping control shall act in accordance with Doping Control Procedures and shall explain all procedures for doping control to the competitor.
L4.3 The competitor shall be given a copy of the doping control form and shall sign it to acknowledge that he or she has been informed of the procedures.
L4.4 The competitor shall provide a postal or fax address at which, during the 60 days following the testing, he or she may be informed of the result of the test of sample B (rule L5).
L4.5 Failure by a competitor to acknowledge receipt of the notice (rule L4.1(b)), to sign the form (rule L4.3) or to provide an address will not to be grounds for cancelling any penalty imposed for breaking rule 5.
L5 Sampling and Results
L5.1 The competitor shall provide a urine sample which will be divided into two samples, A and B, and sent to a designated laboratory.
L5.2 When sample A is negative, the sampling officer shall so inform the competitor immediately and no further action shall be taken.
L5.3 When sample A is positive
(a) the initiating authority shall so inform the competitor and his or her national authority immediately. No race results shall be changed at this stage; and
(b) the laboratory will proceed to test sample B. The competitor or his or her representative may be present at the testing.
L5.4 (a) When sample B is negative, the initiating authority shall so inform the competitor and his or her national authority, and no further action shall be taken.
(b) When no result has been obtained from sample B after 60 days from the date of the testing, the test shall be considered void and no further action shall be taken.
L5.5 When sample B is positive, the ISAF or the initiating national authority will inform the competitor in writing at the address provided (rule L4.4) and his or her national authority. The ISAF will inform the national authority having jurisdiction over the event.
L5.6 (a) Any positive result of a medical test shall be reported promptly by the initiating national authority to the ISAF.
(b) Any penalties imposed by the national authority for breaches of rule 5 or rule L1.2 shall be reported promptly to the ISAF.
L6 Appeal Procedure
L6.1 The competitor has 20 days from the date of the communication required in rule L5.5 to appeal to the International Medical Commission (IMC) of the ISAF. When after 20 days the competitor has not appealed, his or her national authority and that of the event will be notified of this fact.
L6.2 After the last day for submitting an appeal, penalties will be applied and the scores of the competitor and the boat in which he or she was sailing shall be removed from the results of the event.
L7.1 A competitor may ask, only in writing, for prior approval from the IMC for the use of a banned substance or a banned method for special medical reasons. The reasons shall be stated and supported with medical evidence from a doctor.
L7.2 In offshore races of more than 50 nautical miles, the use during the race of any banned substance or banned procedure for emergency medical treatment shall be reported promptly to the protest committee, which shall inform the appropriate national authority and the ISAF. The IMC may retroactively approve such use.
L8 Suspension of ISAF Eligibility
L8.1 In addition to any penalty imposed under rule K3.1, a competitor who has broken rule 5 may have his or her ISAF eligibility suspended as provided in Appendix K.
L8.2 The competitor may appeal as provided in Appendix K.
L9 Competitor's Expenses
Any expenses incurred in connection with this appendix by a competitor shall be his or her responsibility